AI-generated summary
The authors randomized 133 men with benign prostatic hyperplasia to thulium laser (70 W) or holmium laser (90 W) transurethral enucleation of the prostate and followed them for 18 months. They report that both procedures improved urinary symptoms and flow similarly, with thulium showing less blood loss but a longer operation time, differences the authors describe as clinically negligible.
- Participants
- 133
- Who or what was studied
- Men with benign prostatic hyperplasia undergoing transurethral laser enucleation of the prostate
- Limits stated in the abstract
- The abstract describes a single-center study and does not report a total follow-up loss or blinding details.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 70 W, 90 W
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.